These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 22342021)

  • 1. Generic drugs in dermatology: part I.
    Payette M; Grant-Kels JM
    J Am Acad Dermatol; 2012 Mar; 66(3):343.e1-8; quiz 351-2. PubMed ID: 22342021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generic drugs in dermatology: part II.
    Payette M; Grant-Kels JM
    J Am Acad Dermatol; 2012 Mar; 66(3):353.e1-15; quiz 367-8. PubMed ID: 22342022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brand name versus generic drugs: the ethical quandary in caring for our sophisticated patients while trying to reduce health-care costs: facts and controversies.
    Payette M; Grant-Kels JM
    Clin Dermatol; 2013; 31(6):772-6. PubMed ID: 24160285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generic drugs--safe, effective, and affordable.
    Peters JR; Hixon DR; Conner DP; Davit BM; Catterson DM; Parise CM
    Dermatol Ther; 2009; 22(3):229-40. PubMed ID: 19453347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rising drug costs: the impact on dermatology.
    Rico MJ
    Skin Therapy Lett; 2000; 5(4):1-2,5. PubMed ID: 10785406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The rise of the generic drug market and its implications for dermatology.
    Bhosle M; Balkrishnan R; Dewan T; Yelverton CB; Feldman SR
    J Dermatolog Treat; 2005; 16(5-6):295-8. PubMed ID: 16428148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dissecting drug pricing: Supply chain, market, and nonmarket trends impacting clinical dermatology.
    Nguyen HP; Go JA; Barbieri JS; Stough D; Stoff BK; Forman HP; Bolognia JL; Albrecht J;
    J Am Acad Dermatol; 2020 Aug; 83(2):691-699. PubMed ID: 32330637
    [No Abstract]   [Full Text] [Related]  

  • 8. Variation in cash price of the generic medications most prescribed by dermatologists in pharmacies across the United States.
    Alghanem N; Abokwidir M; Fleischer AB; Feldman SR; Alghanem W
    J Dermatolog Treat; 2017 Mar; 28(2):119-128. PubMed ID: 27241622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in Retail Prices of Prescription Dermatologic Drugs From 2009 to 2015.
    Rosenberg ME; Rosenberg SP
    JAMA Dermatol; 2016 Feb; 152(2):158-63. PubMed ID: 26606197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association Between Market Competition and Prices of Generic Topical Dermatology Drugs.
    Li DG; Joyce C; Mostaghimi A
    JAMA Dermatol; 2018 Dec; 154(12):1441-1446. PubMed ID: 30383117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of generic drugs in prevention of chronic disease is far more cost-effective than thought, and may save money.
    Shrank WH; Choudhry NK; Liberman JN; Brennan TA
    Health Aff (Millwood); 2011 Jul; 30(7):1351-7. PubMed ID: 21734210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The clinical and economic impact of generic drugs in the treatment of epilepsy].
    Argumosa A; Herranz JL
    Rev Neurol; 2005 Jul 1-15; 41(1):45-9. PubMed ID: 15999330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The generics in transplantation and the rules on their use.
    Masri M
    Exp Clin Transplant; 2003 Jun; 1(1):65-8. PubMed ID: 15859910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential savings from increased use of generic drugs in the elderly: what the experience of Medicaid and other insurance programs means for a Medicare drug benefit.
    Fischer MA; Avorn J
    Pharmacoepidemiol Drug Saf; 2004 Apr; 13(4):207-14. PubMed ID: 15255087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of generic competition on the price of brand-name drugs.
    Lexchin J
    Health Policy; 2004 Apr; 68(1):47-54. PubMed ID: 15033552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of cost sharing on prescription drugs used by Medicare beneficiaries.
    Goedken AM; Urmie JM; Farris KB; Doucette WR
    Res Social Adm Pharm; 2010 Jun; 6(2):100-9. PubMed ID: 20511109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The state and consequences of dermatology drug prices in the United States.
    Albrecht J; Lebwohl M; Asgari MM; Bennett DD; Cook A; Evans CC; Green LJ; Hodge JA; Kourosh AS; Maloney ME; Howard LM; Olsen EA; Rosenberg SP; Rubin A; Stough DB; Taylor SC; Brod BA
    J Am Acad Dermatol; 2016 Sep; 75(3):603-605. PubMed ID: 27423978
    [No Abstract]   [Full Text] [Related]  

  • 18. Plan designs that encourage the use of generic drugs over brand-name drugs: an analysis of a free generic benefit.
    Rodin HA; Heaton AH; Wilson AR; Garrett NA; Plocher DW
    Am J Manag Care; 2009 Dec; 15(12):881-8. PubMed ID: 20001169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brand Medications and Medicare Part D: How Eye Care Providers' Prescribing Patterns Influence Costs.
    Newman-Casey PA; Woodward MA; Niziol LM; Lee PP; De Lott LB
    Ophthalmology; 2018 Mar; 125(3):332-339. PubMed ID: 28625684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generic medications for you, but brand-name medications for me.
    Keenum AJ; Devoe JE; Chisolm DJ; Wallace LS
    Res Social Adm Pharm; 2012; 8(6):574-8. PubMed ID: 22357268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.